Target intelligence / Profile preview

Otopetrin 1 pseudogene

Molecular classification: Other (Pseudogene)

Overview

Otopetrin 1 pseudogene is a segment of DNA in the human genome that resembles the otopetrin 1 gene but has lost the ability to encode a functional protein product due to the accumulation of disabling mutations[3][4]. Pseudogenes like this are considered genomic relics—they have a high degree of sequence homology to their parental gene but do not yield functional products[3][4]. Currently, there is no evidence of this pseudogene being expressed or having any regulatory, biological, or pathological role. It is not used as a drug target or biomarker and is typically excluded from medical, pharmacological, or physiological research due to its nonfunctional status[3][4][1].

Other names: LOC388996ENSG00000278131otopetrin 1 pseudogene

Beyond the preview

Go deeper on Otopetrin 1 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Otopetrin 1 pseudogene.

Explore the full profile